Testing effectiveness (Phase 2)Looking for participantsNCT05054296
What this trial is testing
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 200